Overall, Le Garff-Tavernier et al. [91] argue that NK phenotypes in CLL (specifically studying the CD16+CD56dim subset) are broadly normal; most other studies do find alterations in NK receptor expression, although the specific differences are not consistent between studies. This evidence concerns the gene FCGR3A and B-cell chronic lymphocytic leukemia.